Cell Lysis Market Size (2024 - 2029)

The cell lysis market is anticipated to experience significant growth, driven by increased research and development expenditures and its expanding application in the pharmaceutical and biopharmaceutical sectors. The demand for cell lysis devices and reagents has surged due to heightened research activities, particularly during the COVID-19 pandemic, which underscored the importance of understanding viral behaviors. The market's expansion is further supported by the rising focus on personalized medicine and the high adoption of cell lysis methods in biotherapeutics manufacturing. Despite these positive trends, challenges such as regulatory compliance and mechanical process issues at the microscale level may impede market growth.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research Cytology Research Cell Lysis Market Market Size

Market Size of Cell Lysis Industry

Cell Lysis Disruption Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.50 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Cell Lysis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Cell Lysis Market Analysis

The cell lysis market is expected to register a CAGR of 8.5% over the forecast period.

Severe respiratory consequences of the COVID-19 pandemic prompted an urgent need for novel therapies that increased the number of drug discoveries, thereby positively impacting the cell lysis market. Several research studies were conducted to understand the effect of cell lysis on coronavirus. For instance, during the peak of the COVID-19 pandemic, the Department of Biotechnology (DBT) in India undertook a project to sequence 1,000 SARS-CoV-2 genomes from samples to understand the evolving behavior of the virus. The samples were collected across India to study the emerging mutations in the virus and how they change the symptoms of the disease. The increase in research activities that used different processes increased the demand for cell lysis devices and reagents.

The market is expected to grow due to increased expenditure on research and development, increasing application in the pharmaceutical and biopharmaceutical industries, and a rising focus on personalized medicine. Personalized medicine is one of the latest developments of gene-related studies that provide custom-tailored treatments as per the specific needs of patients, which has massive significance in disease prevention, diagnosis, prognosis, and therapeutics. According to the GLOBOCAN, in 2020, there were around 19,292,789 new cancer cases worldwide and about 9,958,133 deaths due to cancer. With the increase in the prevalence of infectious diseases and cancers, the use of cell samples for research and development of drugs also increases, which is expected to support the growth of the cell lysis market.

The high adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other recombinant products further boosts the overall market growth. Furthermore, rising investments by governments and private organizations in R&D related to biotechnological processes and academics are expected to drive the market significantly. However, regulatory compliance and issues in the mechanical process in applying at the microscale level are some factors that might hinder market growth.

Cell Lysis Industry Segmentation

As per the scope of the report, cell lysis is one of the major steps in biological research to remove biological materials and use them in various downstream applications to fulfill research goals. Cell lysis is used in many industries, from pharmaceuticals to food, cosmetics, and biotechnology. The cell lysis market is segmented by product (instruments and reagents), type of cells (mammalian cells, microbial cells, and plant cells), end user (biotechnology or biopharmaceutical companies, research laboratories and academic institutes, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers estimated market sizes and trends for 17 different countries across major regions. The report offers all values in USD million for the above segments.

By Type of Product
Instruments
Homogeniser
Centrifugation
Other Types of Products
Reagents
By Type of Cells
Mammalian Cells
Microbial Cells
Plant Cells
By End User
Biotechnology or Biopharmaceutical Companies
Research Laboratories and Academic Institutes
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Cell Lysis Market Size Summary

The cell lysis market is poised for significant growth, driven by increased research and development activities and the rising application of cell lysis techniques in the pharmaceutical and biopharmaceutical sectors. The demand for cell lysis devices and reagents has surged, particularly due to the urgent need for novel therapies during the COVID-19 pandemic, which spurred numerous drug discoveries and research studies. The market is further bolstered by the growing focus on personalized medicine, which tailors treatments to individual patient needs, and the increasing prevalence of infectious diseases and cancers. These factors have led to a heightened use of cell samples in drug research and development, supporting the market's expansion. The adoption of cell lysis methods in the production of biotherapeutics and recombinant products, along with substantial investments in biotechnological research, are also contributing to the market's growth trajectory.

North America leads the cell lysis market, fueled by substantial research and development expenditures and a high incidence of chronic diseases. The region's response to COVID-19, including increased lab testing and vaccine development, has further driven demand for cell lysis systems and reagents. The market is characterized by moderate competition, with both local and international companies like Thermo Fisher Scientific, Merck KGaA, and F. Hoffmann-La Roche Ltd playing significant roles. These companies are focusing on novel product developments and strategic collaborations to strengthen their market positions. The continuous advancement of healthcare infrastructure and the growing patient population in the United States present further opportunities for market expansion. Additionally, recent technological advancements, such as the use of microfluidic devices in cell lysis, are expected to enhance market growth.

Explore More

Cell Lysis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Expenditure in Research and Development

      2. 1.2.2 Increasing Application in the Pharmaceutical and Biopharmaceutical Industries

      3. 1.2.3 Rising Focus on Personalized Medicine

    3. 1.3 Market Restraints

      1. 1.3.1 Regulatory Compliance

      2. 1.3.2 Issues in Mechanical Process to Apply at the Microscale Level

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD million)

    1. 2.1 By Type of Product

      1. 2.1.1 Instruments

        1. 2.1.1.1 Homogeniser

        2. 2.1.1.2 Centrifugation

        3. 2.1.1.3 Other Types of Products

      2. 2.1.2 Reagents

    2. 2.2 By Type of Cells

      1. 2.2.1 Mammalian Cells

      2. 2.2.2 Microbial Cells

      3. 2.2.3 Plant Cells

    3. 2.3 By End User

      1. 2.3.1 Biotechnology or Biopharmaceutical Companies

      2. 2.3.2 Research Laboratories and Academic Institutes

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Cell Lysis Market Size FAQs

The Cell Lysis Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)

Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA and Danaher Corporation are the major companies operating in the Cell Lysis Market.

Cell Lysis Market Report Snapshots

Cell Lysis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)